Cargando…
ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
Cancers must maintain their telomeres at lengths sufficient for cell survival. In several cancer subtypes, a recombination-like mechanism termed alternative lengthening of telomeres (ALT), is frequently used for telomere length maintenance. Cancers utilizing ALT often have lost functional ATRX, a ch...
Autores principales: | Brosnan-Cashman, Jacqueline A., Yuan, Ming, Graham, Mindy K., Rizzo, Anthony J., Myers, Kaylar M., Davis, Christine, Zhang, Rebecca, Esopi, David M., Raabe, Eric H., Eberhart, Charles G., Heaphy, Christopher M., Meeker, Alan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143253/ https://www.ncbi.nlm.nih.gov/pubmed/30226859 http://dx.doi.org/10.1371/journal.pone.0204159 |
Ejemplares similares
-
The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016) -
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
por: Falcinelli, Marta, et al.
Publicado: (2023) -
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
por: Lovejoy, Courtney A., et al.
Publicado: (2012) -
ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015) -
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
por: Hackeng, Wenzel M, et al.
Publicado: (2022)